» Articles » PMID: 30276677

Enhanced Expression of Nidogen 1 Around the Nest of Basal Cell Carcinoma Compared with That Around Squamous Cell Carcinoma

Overview
Journal Med Mol Morphol
Publisher Springer
Date 2018 Oct 3
PMID 30276677
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Basal cell carcinoma (BCC) is a malignant skin tumor originating from cells of the epidermal basal layer and adnexal epithelium, especially in sun-exposed areas. Unlike squamous cell carcinoma (SCC), BCC has a propensity to grow only locally possibly due to differences in the surrounding microenvironment including the basement membrane (BM) and stroma. To investigate the components constituting the BM and surrounding connective tissue in BCC and SCC, we analyzed the expression of BM proteins, nidogen 1 (NID1) and type IV collagen (COL4). We compared the immunohistochemical expressions of NID1 and COL4 among tumor specimens from BCC, SCC and its precancerous condition, actinic keratosis (AK), (n = 5 each condition). The expressions of NID1 and COL4 were both decreased around the tumor nest of SCC. In contrast, the expressions of both NID1 and COL4 around the nest of BCC were much higher than in the peri-lesional normal skin not only at the BM, but also in the surrounding stromal tissue. Our findings imply that the surrounding stromal cells of BCC, but not SCC or AK, excessively produce NID1 and COL4, which may be involved in preventing BCC cells from destroying the BM and invading the dermis.

Citing Articles

Multimodal Considerations Concerning Basal Cell Carcinoma Clefting - Profile of Structural and Aggressive Traits - Perspectives.

Niculet E, Bobeica C, Craescu M, Nicolescu A, Tocu G, Onisor C Clin Cosmet Investig Dermatol. 2022; 15:2087-2095.

PMID: 36199384 PMC: 9529228. DOI: 10.2147/CCID.S385213.


Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment.

Song K, Yu Z, Zu X, Li G, Hu Z, Xue Y Int J Mol Sci. 2022; 23(18).

PMID: 36142424 PMC: 9502421. DOI: 10.3390/ijms231810509.


Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas.

Kavasi R, Neagu M, Constantin C, Munteanu A, Surcel M, Tsatsakis A Front Med (Lausanne). 2022; 9:879500.

PMID: 35572966 PMC: 9100789. DOI: 10.3389/fmed.2022.879500.

References
1.
Diepgen T, Mahler V . The epidemiology of skin cancer. Br J Dermatol. 2002; 146 Suppl 61:1-6. DOI: 10.1046/j.1365-2133.146.s61.2.x. View

2.
Kore-Eda S, Matsuyoshi N, Ueda M, Horiguchi Y, Miyachi Y, Imamura S . A monoclonal antibody established from the immunization of basal cell carcinoma (BCC) tissues reacts to the intercellular space of BCC and hair follicles. J Dermatol. 2002; 29(11):718-25. DOI: 10.1111/j.1346-8138.2002.tb00209.x. View

3.
McNutt N . Ultrastructural comparison of the interface between epithelium and stroma in basal cell carcinoma and control human skin. Lab Invest. 1976; 35(2):132-42. View

4.
Fundyler O, Khanna M, Smoller B . Metalloproteinase-2 expression correlates with aggressiveness of cutaneous squamous cell carcinomas. Mod Pathol. 2004; 17(5):496-502. DOI: 10.1038/modpathol.3800066. View

5.
Mueller M, Fusenig N . Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 2004; 4(11):839-49. DOI: 10.1038/nrc1477. View